Study on pharmacokinetics and pharmacodynamics of ginkgolides in rat model with cerebral ischemia injury
10.7501/j.issn.0253-2670.2018.04.022
- Author:
Jing CHEN
1
Author Information
1. College of Hanlin, Nanjing University of Chinese Medicine
- Publication Type:Journal Article
- Keywords:
Cerebral ischemic injury model;
Ginkgolide B;
Ginkgolides;
Nasal administration;
PK-PD
- From:
Chinese Traditional and Herbal Drugs
2018;49(4):885-890
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the metabolic process of ginkgolides in rats with cerebral ischemic injury based on pharmacokinetic- pharmacodynamics (PK-PD) binding model. Methods The middle cerebral artery occlusion (MCAO) model was established by the suture method. After reperfusion, rats were randomly assigned to nasal administration, ig administration, and iv administration group.The orbital blood was taken at different time points of 0.25, 0.33, 0.5, 0.75, 1.0, 1.25, 1.5, 2.0, 4.0, 6.0, 9.0, and 12.0 h after the administration of the ginkgolides solution. The drug-time curve of ginkgolide B in plasma were drawn according to the concentration measured by LC-MS. The time-effect curve of superoxide dismutase (SOD) and malondialdehyde (MDA) were drawn based on the value measured by the kit. The pharmacokinetic parameters were calculated by DAS 2.0 software to fit the PK-PD binding model. Results The t1/2 of ginkgolide B of the rats in the administration group was smaller than that in the MCAO model group. The area under the curve (AUC) of nasal administration was significantly higher than intragastric administration and intravenous administration. Conclusion Ginkgolide B has a good protective and mitigating effect on ischemic stroke. The pharmacokinetics of nasal administration is better than iv and ig administration, which can provide reference for the development of nasal administration of ginkgolide B.
